Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
3R01AI034235-01S1
Application #
3149190
Study Section
AIDS and Related Research Study Section 2 (ARRB)
Project Start
1993-09-01
Project End
1998-07-31
Budget Start
1993-09-01
Budget End
1994-08-31
Support Year
1
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Onyango-Makumbi, Carolyne; Omer, Saad B; Mubiru, Michael et al. (2011) Safety and efficacy of HIV hyperimmune globulin for prevention of mother-to-child HIV transmission in HIV-1-infected pregnant women and their infants in Kampala, Uganda (HIVIGLOB/NVP STUDY). J Acquir Immune Defic Syndr 58:399-407
Onyango-Makumbi, Carolyne; Bagenda, Danstan; Mwatha, Antony et al. (2010) Early weaning of HIV-exposed uninfected infants and risk of serious gastroenteritis: Findings from two perinatal HIV prevention trials in Kampala, Uganda. J Acquir Immune Defic Syndr 53:20-7
Church, Jessica D; Huang, Wei; Mwatha, Anthony et al. (2010) Analysis of HIV tropism in Ugandan infants. Curr HIV Res 8:498-503
Heaton, R K; Clifford, D B; Franklin Jr, D R et al. (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75:2087-96
Church, Jessica D; Huang, Wei; Parkin, Neil et al. (2009) Comparison of laboratory methods for analysis of non-nucleoside reverse transcriptase inhibitor resistance in Ugandan infants. AIDS Res Hum Retroviruses 25:657-63
Church, Jessica D; Mwatha, Anthony; Bagenda, Danstan et al. (2009) In utero HIV infection is associated with an increased risk of nevirapine resistance in ugandan infants who were exposed to perinatal single dose nevirapine. AIDS Res Hum Retroviruses 25:673-7
Church, Jessica D; Omer, Saad B; Guay, Laura A et al. (2008) Analysis of nevirapine (NVP) resistance in Ugandan infants who were HIV infected despite receiving single-Dose (SD) NVP versus SD NVP plus daily NVP up to 6 weeks of age to prevent HIV vertical transmission. J Infect Dis 198:1075-82
Six Week Extended-Dose Nevirapine (SWEN) Study Team; Bedri, Abubaker; Gudetta, Berhanu et al. (2008) Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials. Lancet 372:300-13
Guay, Laura A; Musoke, Philippa; Hom, David L et al. (2002) Phase I/II trial of HIV-1 hyperimmune globulin for the prevention of HIV-1 vertical transmission in Uganda. AIDS 16:1391-400
Mellquist, J L; Bowman, B; Kasturi, L et al. (1998) Characterization of HIV type 1 gp120 V3 region sequences from Ugandan infants. AIDS Res Hum Retroviruses 14:1391-5

Showing the most recent 10 out of 11 publications